Connection
Daniel Pollyea to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Daniel Pollyea has written about Randomized Controlled Trials as Topic.
|
|
Connection Strength |
|
|
|
|
|
0.160 |
|
|
|
-
Pollyea DA. Venetoclax in AML: Where We Are and Where We Are Headed. Clin Lymphoma Myeloma Leuk. 2020 09; 20 Suppl 1:S25-S26.
Score: 0.128
-
Cortes JE, Heidel FH, Fiedler W, Smith BD, Robak T, Montesinos P, Candoni A, Leber B, Sekeres MA, Pollyea DA, Ferdinand R, Ma WW, O'Brien T, O'Connell A, Chan G, Heuser M. Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy. J Hematol Oncol. 2020 07 14; 13(1):92.
Score: 0.032